We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CYRX market cap is 392.73M. The company's latest EPS is USD -2.1765 and P/E is -3.61.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 56.16M | 57.26M | 54.59M | 57.6M | 56.66M |
| Operating Income | -16.91M | -69.87M | -21.28M | -15.82M | -16.43M |
| Net Income | -15.27M | -64.39M | -20.9M | -79.99M | -1.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 33.94M | 78.7M | 222.61M | 237.28M | 233.26M |
| Operating Income | -17.68M | -30.01M | -17.83M | -31.9M | -115.16M |
| Net Income | -18.33M | -75.03M | -283.72M | -45.33M | -107.59M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1B | 957.74M | 942.85M | 852.34M | 701.77M |
| Total Liabilities | 463.13M | 468.72M | 470.66M | 452.25M | 283.19M |
| Total Equity | 537.53M | 489.02M | 472.19M | 400.1M | 418.57M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 135.87M | 552.41M | 1.11B | 1.04B | 957.74M |
| Total Liabilities | 9.59M | 169.71M | 471.14M | 482.91M | 468.72M |
| Total Equity | 126.28M | 382.7M | 641.83M | 555.84M | 489.02M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.24M | -757k | -3.27M | -11.29M | -10.84M |
| Investing | 50.81M | 36.05M | 6.45M | 19.77M | 173.34M |
| Financing | -23.67M | -23.8M | -45k | -8.25M | -163.54M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.32M | -14.87M | 8.13M | -1.85M | -757k |
| Investing | -62.93M | -382.31M | -469.25M | -59.68M | 36.05M |
| Financing | 74.15M | 385.59M | 564.34M | -39.17M | -23.8M |
| Market Cap | 392.73M |
| Price to Earnings Ratio | -3.61 |
| Price to Sales Ratio | 1.66 |
| Price to Cash Ratio | 8.37 |
| Price to Book Ratio | 0.79 |
| Dividend Yield | - |
| Shares Outstanding | 49.43M |
| Average Volume (1 week) | 160.2k |
| Average Volume (1 Month) | 324.39k |
| 52 Week Change | -48.34% |
| 52 Week High | 20.105 |
| 52 Week Low | 5.315 |
| Spread (Intraday) | 0.07 (0.88%) |
| Company Name | CryoPort Inc |
| Address |
112 north curry st carson city, nevada 89703 |
| Website | https://www.cryoport.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
